Page last updated: 2024-09-04

ivabradine and cisapride

ivabradine has been researched along with cisapride in 1 studies

Compound Research Comparison

Studies
(ivabradine)
Trials
(ivabradine)
Recent Studies (post-2010)
(ivabradine)
Studies
(cisapride)
Trials
(cisapride)
Recent Studies (post-2010) (cisapride)
1,1431978331,554390110

Protein Interaction Comparison

ProteinTaxonomyivabradine (IC50)cisapride (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.767
3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)3.37
Cytochrome P450 3A4Homo sapiens (human)0.3
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.0098
Alpha-2A adrenergic receptorHomo sapiens (human)3.5923
Cytochrome P450 2D6Homo sapiens (human)0.07
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.1701
D(2) dopamine receptorHomo sapiens (human)0.35
Dipeptidyl peptidase 4Rattus norvegicus (Norway rat)2.69
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.0098
Insulin receptor Rattus norvegicus (Norway rat)3.37
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)2.29
Alpha-2B adrenergic receptorHomo sapiens (human)3.3827
Alpha-2C adrenergic receptorHomo sapiens (human)3.26
DRattus norvegicus (Norway rat)0.0065
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)3.6495
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.0065
D(1A) dopamine receptorHomo sapiens (human)1.7
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.0065
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.0065
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)2.29
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.0065
Alpha-1D adrenergic receptorHomo sapiens (human)0.083
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0054
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.2597
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)3.6495
5-hydroxytryptamine receptor 1DRattus norvegicus (Norway rat)4.47
5-hydroxytryptamine receptor 1FRattus norvegicus (Norway rat)4.47
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.0098
Sodium-dependent serotonin transporterHomo sapiens (human)0.384
Alpha-1A adrenergic receptorHomo sapiens (human)0.03
Prostaglandin G/H synthase 2Homo sapiens (human)3.37
Alpha-1B adrenergic receptorHomo sapiens (human)0.03
D(3) dopamine receptorHomo sapiens (human)0.144
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.9
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0407
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)2.29
D(2) dopamine receptorRattus norvegicus (Norway rat)0.535
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.2536
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)0.1701
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.994
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellin, M; Chen, Z; Dorn, T; Dreizehnter, L; Goedel, A; Hinkel, R; Laugwitz, KL; Lipp, P; Moretti, A; Mummery, CL; Ng, JK; Pane, LS; Schneider, CM; Sinnecker, D; Tian, Q; Ward-van Oostwaard, D; Xian, W1

Other Studies

1 other study(ies) available for ivabradine and cisapride

ArticleYear
Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.
    European heart journal, 2017, 01-21, Volume: 38, Issue:4

    Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Cisapride; Drug Evaluation; Humans; Induced Pluripotent Stem Cells; Ivabradine; Long QT Syndrome; Luminescent Proteins; Models, Cardiovascular; Myocytes, Cardiac; Potassium Channel Blockers; Voltage-Sensitive Dye Imaging

2017